Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D Huntington

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Immunology and Cell Biology|November 20, 2023
Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy frayNicholas S Wilson, Nicholas D Huntington
Nature Reviews. Cancer|June 26, 2020
The cancer-natural killer cell immunity cycleNicholas D Huntington, Joseph Cursons, Jai Rautela
Journal of Leukocyte Biology|January 19, 2021
Drug target validation in primary human natural killer cells using CRISPR RNPJai Rautela, Elliot Surgenor, Nicholas D Huntington
Immunology and Cell Biology|January 23, 2018
A new checkpoint for Natural Killer cell activationFernando Souza-Fonseca-Guimaraes, Nicholas D Huntington
Cancers|August 24, 2019
Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune ResponseCarolyn Shembrey, Nicholas D Huntington, Frédéric Hollande
Oncotarget|October 17, 2015
DNAM-1: would the real natural killer cell please stand up!Nicholas D Huntington, Ludovic Martinet, Mark J Smyth
Current Opinion in Immunology|July 14, 2023
Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunityHarrison Sudholz, Rebecca B Delconte, Nicholas D Huntington
Frontiers in Immunology|February 7, 2013
Regulation of murine natural killer cell commitmentNicholas D Huntington, Stephen L Nutt, Sebastian Carotta
Current Topics in Microbiology and Immunology|August 26, 2015
Development, Homeostasis, and Heterogeneity of NK Cells and ILC1Cyril Seillet, Gabrielle T Belz, Nicholas D Huntington
Nature Immunology|August 20, 2016
Targeting natural killer cells in cancer immunotherapyCamille Guillerey, Nicholas D Huntington, Mark J Smyth
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Immunology and Cell Biology|November 20, 2023
Small molecule. Big biology. Dual phosphatase inhibitor enters the immunotherapy frayNicholas S Wilson, Nicholas D Huntington
Nature Reviews. Cancer|June 26, 2020
The cancer-natural killer cell immunity cycleNicholas D Huntington, Joseph Cursons, Jai Rautela
Journal of Leukocyte Biology|January 19, 2021
Drug target validation in primary human natural killer cells using CRISPR RNPJai Rautela, Elliot Surgenor, Nicholas D Huntington
Immunology and Cell Biology|January 23, 2018
A new checkpoint for Natural Killer cell activationFernando Souza-Fonseca-Guimaraes, Nicholas D Huntington
Cancers|August 24, 2019
Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune ResponseCarolyn Shembrey, Nicholas D Huntington, Frédéric Hollande
Oncotarget|October 17, 2015
DNAM-1: would the real natural killer cell please stand up!Nicholas D Huntington, Ludovic Martinet, Mark J Smyth
Current Opinion in Immunology|July 14, 2023
Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunityHarrison Sudholz, Rebecca B Delconte, Nicholas D Huntington
Frontiers in Immunology|February 7, 2013
Regulation of murine natural killer cell commitmentNicholas D Huntington, Stephen L Nutt, Sebastian Carotta
Current Topics in Microbiology and Immunology|August 26, 2015
Development, Homeostasis, and Heterogeneity of NK Cells and ILC1Cyril Seillet, Gabrielle T Belz, Nicholas D Huntington
Nature Immunology|August 20, 2016
Targeting natural killer cells in cancer immunotherapyCamille Guillerey, Nicholas D Huntington, Mark J Smyth
Pageof 14